Cite
VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer.
MLA
Loehrer, P. J., Sr, et al. “VP-16 plus Ifosfamide plus Cisplatin as Salvage Therapy in Refractory Germ Cell Cancer.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 4, no. 4, Apr. 1986, pp. 528–36. EBSCOhost, https://doi.org/10.1200/JCO.1986.4.4.528.
APA
Loehrer, P. J., Sr, Einhorn, L. H., & Williams, S. D. (1986). VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 4(4), 528–536. https://doi.org/10.1200/JCO.1986.4.4.528
Chicago
Loehrer, P J, Sr, L H Einhorn, and S D Williams. 1986. “VP-16 plus Ifosfamide plus Cisplatin as Salvage Therapy in Refractory Germ Cell Cancer.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 4 (4): 528–36. doi:10.1200/JCO.1986.4.4.528.